Vicarious Surgical (NYSE:RBOT) Upgraded by Wall Street Zen to “Hold” Rating

Vicarious Surgical (NYSE:RBOT) was upgraded by equities research analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a report released on Sunday.

RBOT has been the subject of a number of other research reports. Weiss Ratings reissued a “sell (e+)” rating on shares of Vicarious Surgical in a research report on Wednesday, January 21st. BTIG Research reiterated a “neutral” rating on shares of Vicarious Surgical in a research note on Friday, December 12th. Two analysts have rated the stock with a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Reduce” and an average price target of $7.00.

Vicarious Surgical Stock Up 5.9%

Shares of NYSE:RBOT opened at $1.96 on Friday. Vicarious Surgical has a 12-month low of $1.81 and a 12-month high of $16.35. The business has a 50 day moving average of $2.43 and a 200-day moving average of $4.84. The stock has a market cap of $12.84 million, a PE ratio of -0.22 and a beta of 1.54.

Vicarious Surgical (NYSE:RBOT) last released its quarterly earnings results on Wednesday, November 12th. The company reported ($1.91) earnings per share for the quarter, topping the consensus estimate of ($2.37) by $0.46. Equities research analysts expect that Vicarious Surgical will post -10.89 earnings per share for the current year.

Institutional Investors Weigh In On Vicarious Surgical

Several institutional investors and hedge funds have recently bought and sold shares of the company. DNB Asset Management AS grew its stake in Vicarious Surgical by 12.1% during the second quarter. DNB Asset Management AS now owns 29,199 shares of the company’s stock worth $219,000 after buying an additional 3,154 shares in the last quarter. Connective Capital Management LLC bought a new stake in shares of Vicarious Surgical during the 3rd quarter worth approximately $169,000. Finally, Dimensional Fund Advisors LP boosted its position in shares of Vicarious Surgical by 22.1% during the 3rd quarter. Dimensional Fund Advisors LP now owns 19,975 shares of the company’s stock worth $110,000 after acquiring an additional 3,615 shares in the last quarter. Institutional investors own 47.27% of the company’s stock.

Vicarious Surgical Company Profile

Vicarious Surgical develops a next-generation robotic surgical system that integrates virtual reality (VR) with minimally invasive instrumentation. Its flagship offering combines ultra-slender, articulated robotic arms with a VR surgeon console, allowing physicians to perform laparoscopic procedures with enhanced precision, dexterity and visual immersion. The platform is designed to reduce patient trauma compared with traditional open or laparoscopic surgery and to expand surgeon access to challenging operative sites.

The company’s technology is intended for use across multiple surgical specialties, including general surgery, gynecology and urology.